Article Versions Notes

Liu C-H, Huang S-C, Yin C-H, Huang W-C, Chen J-S, Chen Y-S, Gan S-T, Tzou S-J, Hsu C-T, Wu H-M, et al. Atrial Fibrillation Risk and Urate-Lowering Therapy in Patients with Gout: A Cohort Study Using a Clinical Database. Biomedicines. 2023; 11(1):59. https://doi.org/10.3390/biomedicines11010059

Liu, Ching-Han, Shih-Chung Huang, Chun-Hao Yin, Wei-Chun Huang, Jin-Shuen Chen, Yao-Shen Chen, Su-Ting Gan, Shiow-Jyu Tzou, Ching-Tsai Hsu, Hao-Ming Wu, and et al. 2023. "Atrial Fibrillation Risk and Urate-Lowering Therapy in Patients with Gout: A Cohort Study Using a Clinical Database" Biomedicines 11, no. 1: 59. https://doi.org/10.3390/biomedicines11010059

Liu, C.-H., Huang, S.-C., Yin, C.-H., Huang, W.-C., Chen, J.-S., Chen, Y.-S., Gan, S.-T., Tzou, S.-J., Hsu, C.-T., Wu, H.-M., & Wang, W.-H. (2023). Atrial Fibrillation Risk and Urate-Lowering Therapy in Patients with Gout: A Cohort Study Using a Clinical Database. Biomedicines, 11(1), 59. https://doi.org/10.3390/biomedicines11010059